Defining an Ultra-Low Risk Group in Asymptomatic IgM Monoclonal Gammopathy

MLA

Dolors Colomer, et al. “Defining an Ultra-Low Risk Group in Asymptomatic IgM Monoclonal Gammopathy.” Cancers, vol. 13, no. 2055, Apr. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d98f3a2911705a8b16d081a4668b1ddf&authtype=sso&custid=ns315887.

APA

Dolors Colomer, Joan Bladé, Natalia Tovar, Beatriz Martín-Antonio, Ignacio Isola, Arturo Pereira, Mari Pau Mena, Luis Gerardo Rodríguez-Lobato, Carlos Fernández de Larrea, Aina Oliver-Caldés, María Teresa Cibeira, Raquel Jiménez-Segura, María Rozman, Laura Magnano, David Moreno, Laura Rosiñol, & Mónica López-Guerra. (2021). Defining an Ultra-Low Risk Group in Asymptomatic IgM Monoclonal Gammopathy. Cancers, 13(2055).

Chicago

Dolors Colomer, Joan Bladé, Natalia Tovar, Beatriz Martín-Antonio, Ignacio Isola, Arturo Pereira, Mari Pau Mena, et al. 2021. “Defining an Ultra-Low Risk Group in Asymptomatic IgM Monoclonal Gammopathy.” Cancers 13 (2055). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d98f3a2911705a8b16d081a4668b1ddf&authtype=sso&custid=ns315887.